Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Scheibenbogen

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Journal of Leukocyte Biology|July 1, 1991
Developmental regulation of the cytokine repertoire in human macrophages: IL-1, IL-6, TNF-alpha, and M-CSFC Scheibenbogen, R Andreesen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patientsC Scheibenbogen, W Hunstein, U Keilholz
Journal of Immunological Methods|March 31, 1998
Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral bloodA Schmittel, U Keilholz, C Scheibenbogen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Biological response to intrahepatic adoptive immunotherapy with autologous interferon activated macrophagesB Hennemann, C Scheibenbogen, R Andreesen
Scandinavian Journal of Immunology|December 1, 1995
Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytesA Schmittel, C Scheibenbogen, U Keilholz
Annals of the Rheumatic Diseases|February 1, 1993
Rheumatic disease following immunotherapyC Scheibenbogen, U Keilholz, A Pezzutto, et al.
Haemostasis|January 1, 1992
Interferon-gamma-induced expression of tissue factor activity during human monocyte to macrophage maturationC Scheibenbogen, H Moser, S Krause, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1995
Intrahepatic adoptive immunotherapy with autologous tumorcytotoxic macrophages in patients with cancerB Hennemann, C Scheibenbogen, C Schümichen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Quantification of tumor-specific T lymphocytes with the ELISPOT assayA Schmittel, U Keilholz, E Thiel, et al.
Onkologie|July 31, 2001
Rational development of peptide vaccination in clinical oncologyU Keiholz, C Scheibenbogen, E Theil, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Journal of Leukocyte Biology|July 1, 1991
Developmental regulation of the cytokine repertoire in human macrophages: IL-1, IL-6, TNF-alpha, and M-CSFC Scheibenbogen, R Andreesen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patientsC Scheibenbogen, W Hunstein, U Keilholz
Journal of Immunological Methods|March 31, 1998
Evaluation of the interferon-gamma ELISPOT-assay for quantification of peptide specific T lymphocytes from peripheral bloodA Schmittel, U Keilholz, C Scheibenbogen
European Journal of Cancer (Oxford, England : 1990)|January 1, 1995
Biological response to intrahepatic adoptive immunotherapy with autologous interferon activated macrophagesB Hennemann, C Scheibenbogen, R Andreesen
Scandinavian Journal of Immunology|December 1, 1995
Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytesA Schmittel, C Scheibenbogen, U Keilholz
Annals of the Rheumatic Diseases|February 1, 1993
Rheumatic disease following immunotherapyC Scheibenbogen, U Keilholz, A Pezzutto, et al.
Haemostasis|January 1, 1992
Interferon-gamma-induced expression of tissue factor activity during human monocyte to macrophage maturationC Scheibenbogen, H Moser, S Krause, et al.
Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1995
Intrahepatic adoptive immunotherapy with autologous tumorcytotoxic macrophages in patients with cancerB Hennemann, C Scheibenbogen, C Schümichen, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Quantification of tumor-specific T lymphocytes with the ELISPOT assayA Schmittel, U Keilholz, E Thiel, et al.
Onkologie|July 31, 2001
Rational development of peptide vaccination in clinical oncologyU Keiholz, C Scheibenbogen, E Theil, et al.
Pageof 7